Tequin (gatifloxacin) is now contraindicated for diabetes patients
March 2006
Tequin (gatifloxacin) is now contraindicated for diabetes patients.
In January, we told you about the many reports of hyper- and hypoglycemia associated with Tequin...especially in diabetes patients.
Also watch for patients at risk for blood glucose problems with Tequin due to advanced age or renal insufficiency.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote